NOUV - Nouveau Life Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0006
+0.0001 (+20.00%)
As of 10:31AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.0005
Open0.0005
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0005 - 0.0006
52 Week Range0.0000 - 0.0021
Volume4,574,585
Avg. Volume47,787,252
Market Cap2.61M
Beta (3Y Monthly)-18.31
PE Ratio (TTM)N/A
EPS (TTM)-0.0170
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire22 hours ago

    ALYI Reports First Revenue From New Energy Storage Innovation Business Focus

    DALLAS, April 22, 2019 -- via OTC PR WIRE -- Alternet Systems, Inc. (USOTC: ALYI) (“ALYI”) recently posted its 2018 financial statement reporting its first quarter million in.

  • GlobeNewswire5 days ago

    ALYI - Alternet Systems Presents $50 Million African Electric Vehicle Strategy

    DALLAS, April 18, 2019 -- via OTC PR WIRE -- Alternet Systems, Inc. (USOTC: ALYI) (“ALYI”) today published a presentation to provide details on the company’s plan to create.

  • GlobeNewswire6 days ago

    Kali Extracts Presents Cannabis Extract Biopharmaceutical Strategy Targeting $170 Million Pharmaceutical Market Opportunity

    DALLAS, April 17, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today published a presentation elaborating on the company’s overall strategy to discover, develop and commercialize novel therapeutics from its proprietary cannabinoid product platform.  KALY owns and operates a patented cannabis extraction process.

  • GlobeNewswire14 days ago

    Kali-Extracts Announces Cannabis Treatment For $9 Billion Epilepsy Market Under Development

    DALLAS, April 09, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a treatment for epilepsy derived.

  • GlobeNewswire18 days ago

    Kali-Extracts Confirms 4th Cannabis Extract Pharmaceutical Research Project Adding To Research Targeting $160 Million Market

    DALLAS, April 05, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed plans to reveal a fourth research.

  • GlobeNewswire19 days ago

    Kali-Extracts Announces Developing Cannabis Pain Management Treatment For $83 Billion Market Specifically Targeting Cancer

    DALLAS, April 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced its ongoing research and development of a cannabis pain management treatment derived from the company’s patented cannabis extraction process.  While cannabis for pain management treatment from cancer is not new, KALY is developing a proprietary extract that improves upon the cannabis treatments currently approved by the FDA.  The FDA approved a marijuana treatment for aiding in the management of cancer symptoms and the side effects of other cancer treatments in 1985.

  • GlobeNewswire21 days ago

    KALY - Kali-Extracts Develops Cannabis Treatment For Type 2 Diabetes Expected To Be $64 Billion Market

    DALLAS, April 02, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today unveiled its ongoing research and development.

  • KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market
    GlobeNewswire25 days ago

    KALY - Kali-Extracts Announces 25 mg CBD Extract Formulation For $600 Million Cannabis Beverage Market

    DALLAS, March 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion.  KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (PURA) (“PURA”) leading EVERx CBD Sports Water.  Few CBD beverages today even have 5 mg of CBD and now KALY will supply a 25 mg formulation.  Management thoroughly evaluated the 25 mg CBD formulation for infusion into a drink that is clear looking and tasting in a suspension with an effective retail shelf-life.  KALY indicates its formulation will be on shelves infused into its first beverage within the next 30 days. KALY earlier this week announced that the State of Texas plans to remove hemp as a controlled substance next week in conjunction with the United States 2018 Farm Act is just the type of market condition management is looking for to support the implantation of the previously announced cannabis extraction lab to be dedicated to the 100 acre hemp farm to be operated by partner Nouveau (NOUV).  KALY and NOUV plan to partner on the development of a proprietary hemp cultivar dedicated to the advancement of KALY’s pharmaceutical extract developments.  The continuing liberalization of cannabis laws, such as the hemp removal as a controlled substance in Texas, supports the work KALY is advancing.

  • GlobeNewswire28 days ago

    KALY Announces A New Step Forward For Its Cannabis Extraction Lab

    DALLAS, March 26, 2019 -- via OTC PR WIRE --  Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced that the State of Texas plans to.

  • GlobeNewswirelast month

    USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY

    DALLAS, March 22, 2019 -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today published an update on.

  • GlobeNewswirelast month

    USMJ and PURA Confirm Respective Dividend Distribution Commitments

    DALLAS, Texas, March 14, 2019 -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) and Puration Inc. (USOTC: PURA) (“PURA”) today confirmed that.

  • GlobeNewswire2 months ago

    ALYI Targets $100 Billion in Anticipated Investment Announcing New York Licensed Hemp Energy Storage Research Facility

    DALLAS, Texas, March 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (ALYI) (“ALYI”) today announced a license in the State of New York to grow hemp. The company has secured acreage in New York to grow and house the facility where hemp bast will be harvested for conducting further research within in the company’s hemp energy storage imitative.  ALYI launched its hemp energy storage initiative late last year when the company brought Clarkson University Professor David Mitlin on board to lead a hemp energy storage initiative.

  • GlobeNewswire3 months ago

    ALYI Announces Forbes Article Featuring ALYI's Hemp Energy Storage Project Lead David Mitlin

    DALLAS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (ALYI) (“ALYI”) today announced that the company's hemp energy storage project lead was featured in an online publication through Forbes. In October last year, Alternet initiated a project to explore and develop hemp-based technologies for energy storage. The company engaged Clarkson University Professor David Mitlin to lead the initiative.

  • GlobeNewswire3 months ago

    ALYI Carves Out Niche In $10 Billion Industrial Hemp Market Accelerated By 2018 Farm Act Legalizing US Hemp Farming

    DALLAS, Jan. 29, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Alternet Systems, Inc. (ALYI) (“ALYI”) today released a management update highlighting the company’s hemp energy initiative in light of the 2018 Farm Act legalizing the farming of hemp in the United States, and providing the latest developments with $1.5 million in ReVolt Electric Motorcycle orders.  ALYI is focused on offering varied, environmentally sustainable, energy storage solutions for targeted markets, including consumer electric vehicles and military applications. The Company has a number of strategic initiatives underway.  The primary focus of the update today is ALYI’s two leading initiatives, the development of hemp energy storage and the production and sales of electric motorcycles.  A recent research report from Grand View Research anticipates the industrial hemp market to grow to $10.6 billion by 2025.  Forbes recently featured the niche within the industrial hemp market that ALYI is targeting.  In fact, the Forbes article featured the consultant engaged by ALYI to accelerate ALYI’s program.

  • GlobeNewswire3 months ago

    PURA Announces Home-Grown Hemp For EVERx In Deal With KALY and NOUV

    DALLAS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Puration, Inc. (PURA) (“PURA”) today announced a home-grown source of hemp for its CBD extractions to go into its EVERx CBD Sports Water. PURA has partnered with Nouveau, Inc. (NOUV) and Kali-Extracts (KALY) to source CBD from NOUV’s hemp cultivation operation and KALY’s proprietary extraction process.

  • GlobeNewswire3 months ago

    Nouveau Inc Moves Forward On Dividend To Puration Inc Shareholders Updating Nevada Registration

    DALLAS, Jan. 16, 2019 -- via OTC PR WIRE – Nouveau Life Pharmaceuticals, Inc. (dba/Nouveau Inc.) (USOTC: NOUV) (“NOUV”) and Puration, Inc. (USOTC: PURA) (“PURA”) today.

  • GlobeNewswire3 months ago

    Nouveau Inc. Announces Brian Shibley CEO of PURA as Interim CEO of NOUV

    DALLAS, Jan. 15, 2019 -- via OTC PR WIRE – Nouveau Life Pharmaceuticals, Inc. (dba/Nouveau Inc.) (USOTC: NOUV) (“NOUV”) and Puration, Inc. (USOTC: PURA) (“PURA”) today.

  • GlobeNewswire3 months ago

    Generex Biotechnology Introduces Treatment Alternative to $6 Billion Ulcerative Colitis Surgery Market

    MIRAMAR, Fla., Jan. 07, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE  -- Generex Biotechnology Corporation (GNBT) is pleased to announce that the company has completed the acquisition of 51% of Regentys™ Corporation, a regenerative medicine company focused on developing novel treatments for patients with gastrointestinal (GI) disorders. The terms of the deal include the previously reported upfront payment of $400,000, plus $14.6 million to be paid according to a milestone-based schedule.

  • GlobeNewswire3 months ago

    KALY - Kali-Extracts Analyst Research Report Featuring New Cannabis Biotechnology Business Set For Release Tomorrow

    DALLAS, Jan. 07, 2019 -- via OTC PR WIRE --  Kali, Inc. (dba/Kali-Extracts) (USOTC: KALY) (“KALY”) today confirmed the previously announced analyst research report featuring.

  • GlobeNewswire4 months ago

    GNBT – Generex Biotechnology Plans Breast Cancer Vaccine Spinout and Dividend

    MIRAMAR, Fla., Jan. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Generex Biotechnology Corporation (GNBT) is pleased to provide an update on operational and strategic developments at NuGenerex Immuno-Oncology (previously Antigen Express), a wholly-owned subsidiary. The protocol for the Phase II clinical trial of pembrolizumab (Keytruda®) in combination with the AE37 Peptide Vaccine in patients with metastatic triple negative breast cancer is under review at the Institutional Review Board (IRB) with oversight of this NSABP Foundation managed study. “With the initiation of the AE37/PD-1 Inhibitor combination trial and the advancement of the company’s clinical development partnership with Shenzhen BioScien for AE37 in prostate cancer, we have validated the Ii-Key technology, as a viable immunotherapy platform,” said Richard Purcell, SVP of R&D at Generex.

  • GlobeNewswire4 months ago

    USMJ CEO 2019 New Year Msg Outlining $20 M Revenue Goal for USMJ Family of Companies – PURA KALY PJET NOUV

    DALLAS, Jan. 04, 2019 -- via OTC PR WIRE – North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today released a 2019 New Year message from the CEO and Chairman Steven.

  • GlobeNewswire4 months ago

    UPDATE -- Generex Biotechnology Makes Major Advance On $22 Billion Wound Care Market Announcing Milestone Agreement

    Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for Excellagen® Wound Healing Collagen Matrix Collagen Solutions & Berkshire Sterile.

  • GlobeNewswire4 months ago

    Kali-Extracts and Nouveau Anticipate $5 Million In Potential Revenue From Hemp Cultivation And Extraction Venture

    DALLAS, Dec. 31, 2018 -- via OTC PR WIRE -- Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) and Nouveau Life Pharmaceuticals, Inc. (dba/Nouveau, Inc) (USOTC: NOUV).

  • GlobeNewswire4 months ago

    Puration Inc Cannabis Beverage Appeal Refreshed with Anheuser Busch and Tilray Deal

    DALLAS, Dec. 26, 2018 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) today reemphasized the company’s cannabis beverage industry experience and direction in light.

  • GlobeNewswire4 months ago

    Kali-Extracts and Nouveau Announce Cannabis Extraction Partnership For Canadian Recreational Marijuana Market

    DALLAS, Dec. 21, 2018 -- via OTC PR WIRE --  Kali, Inc. (dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced plans with Nouveau Life Pharmaceuticals (USOTC: NOUV).